• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

theft

  1. Oncology ARM

    i wonder if BMS HR and the ARM team would be interested to know the the Oncology ARM in NYC has been working for Lilly Oncology for the last 3 years. How LONG has she been working for BMS Oncology? Lilly just found out and forced her to resign. That kind of ethical pervert should be fired from...
Top Bottom
Back